BASILEA PHARMACEUTICA INTERNATIONAL SA, ALLSCHWIL

From the company

Together, we make a difference Here's to 25 years of achievements, innovation, andcollaboration. Together, we continue to make a difference for patients around the world. More on 25 years Basilea We are committed to developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with severe and life-threatening bacterial and fungal infections. Basilea is located in the Basel area, Switzerland and listed on the SIX Swiss Exchange (SIX: BSLN). Half-Year Report 2026 Half-year 2026 update by David Veitch David Veitch, CEO: "Our goal is to become a leading anti-infectives company and serve patients around the world." News Sep 14. 2026 Basilea announces start of clinical study by partner Asahi Kasei Therapeutics in Japan with antifungal Cresemba® (isavuconazole) in pediatric patients Read more Aug 18. 2026 / Ad hoc announcement Basilea reports strong.